BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu X, Chen L, Zhang T. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma. Cancer Control 2018;25:1073274818778001. [PMID: 29843532 DOI: 10.1177/1073274818778001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Ding D, Zhang Y, Zhang X, Shi K, Shang W, Ying J, Wang L, Chen Z, Hong H. MiR-30a-3p Suppresses the Growth and Development of Lung Adenocarcinoma Cells Through Modulating GOLM1/JAK-STAT Signaling. Mol Biotechnol 2022. [PMID: 35438415 DOI: 10.1007/s12033-022-00497-x] [Reference Citation Analysis]
2 Chen J, Liu X, Ke K, Zou J, Gao Z, Habuchi T, Yang X. LINC00992 contributes to the oncogenic phenotypes in prostate cancer via targeting miR-3935 and augmenting GOLM1 expression. BMC Cancer 2020;20:749. [PMID: 32781986 DOI: 10.1186/s12885-020-07141-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li XM, Cao LL. Identification of GOLM1 as a positively regulator of tumor metastasis by regulating MMP13 in gastric carcinoma. Cancer Biomark 2019;26:421-30. [PMID: 31640085 DOI: 10.3233/CBM-190301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Liu Y, Hu X, Liu S, Zhou S, Chen Z, Jin H. Golgi Phosphoprotein 73: The Driver of Epithelial-Mesenchymal Transition in Cancer. Front Oncol 2021;11:783860. [PMID: 34950590 DOI: 10.3389/fonc.2021.783860] [Reference Citation Analysis]
5 Xiong Y, Lei J, Zhao J, Lu Q, Feng Y, Qiao T, Xin S, Han Y, Jiang T. A gene-based survival score for lung adenocarcinoma by multiple transcriptional datasets analysis. BMC Cancer 2020;20:1046. [PMID: 33129284 DOI: 10.1186/s12885-020-07473-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Song Q, He X, Xiong Y, Wang J, Zhang L, Leung EL, Li G. The functional landscape of Golgi membrane protein 1 (GOLM1) phosphoproteome reveal GOLM1 regulating P53 that promotes malignancy. Cell Death Discov 2021;7:42. [PMID: 33649292 DOI: 10.1038/s41420-021-00422-2] [Reference Citation Analysis]
7 Liu S, Wang H, Jiang X, Ji Y, Wang Z, Zhang Y, Wang P, Xiao H. Integrated N-glycoproteomics Analysis of Human Saliva for Lung Cancer. J Proteome Res 2022. [PMID: 35715216 DOI: 10.1021/acs.jproteome.1c00701] [Reference Citation Analysis]
8 He J, Liu Y, Zhang L, Zhang H. Integrin Subunit beta 8 (ITGB8) Upregulation Is an Independent Predictor of Unfavorable Survival of High-Grade Serous Ovarian Carcinoma Patients. Med Sci Monit 2018;24:8933-40. [PMID: 30531684 DOI: 10.12659/MSM.911518] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
9 Zhao M, Li X, Chen X. GOLM1 predicts poor prognosis of patients with NSCLC and is associated with the proliferation and chemo-sensitivity of cisplatin in NSCLC cells: bioinformatics analysis and laboratory validation. J Bioenerg Biomembr 2021;53:177-89. [PMID: 33538941 DOI: 10.1007/s10863-021-09875-7] [Reference Citation Analysis]
10 Pu Y, Song Y, Zhang M, Long C, Li J, Wang Y, Xu Y, Pan F, Zhao N, Zhang X, Xu Y, Cui J, Wang H, Li Y, Zhao Y, Jin D, Zhang H. GOLM1 restricts colitis and colon tumorigenesis by ensuring Notch signaling equilibrium in intestinal homeostasis. Signal Transduct Target Ther 2021;6:148. [PMID: 33850109 DOI: 10.1038/s41392-021-00535-1] [Reference Citation Analysis]
11 Jiang A, Wang J, Liu N, Zheng X, Li Y, Ma Y, Zheng H, Chen X, Fan C, Zhang R, Fu X, Yao Y. Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Data to Establish and Validate a Prognostic Model for Patients With Lung Adenocarcinoma. Front Genet 2022;13:833797. [PMID: 35154287 DOI: 10.3389/fgene.2022.833797] [Reference Citation Analysis]
12 Liewen H, Markuly N, Läubli H, Liu Y, Matter MS, Liewen N, Renner C, Zippelius A, Stenner F. Therapeutic Targeting of Golgi Phosphoprotein 2 (GOLPH2) with Armed Antibodies: A Preclinical Study of Anti-GOLPH2 Antibody Drug Conjugates in Lung and Colorectal Cancer Models of Patient Derived Xenografts (PDX). Target Oncol 2019;14:577-90. [PMID: 31541350 DOI: 10.1007/s11523-019-00667-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Chen J, Liu X, Ke K, Zou J, Gao Z, Habuchi T, Yang X. LINC00992 contributes to the oncogenic phenotypes in prostate cancer via targeting miR-3935 and augmenting GOLM1 expression. BMC Cancer 2020;20:749. [PMID: 32781986 DOI: 10.1186/s12885-020-07141-4] [Reference Citation Analysis]